252 related articles for article (PubMed ID: 25249559)
1. Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD.
Palmer ND; Ng MC; Langefeld CD; Divers J; Lea JP; Okusa MD; Kimberly RP; Bowden DW; Freedman BI
J Am Soc Nephrol; 2015 May; 26(5):1021-5. PubMed ID: 25249559
[TBL] [Abstract][Full Text] [Related]
2. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
[TBL] [Abstract][Full Text] [Related]
3. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
Langefeld CD; Comeau ME; Ng MCY; Guan M; Dimitrov L; Mudgal P; Spainhour MH; Julian BA; Edberg JC; Croker JA; Divers J; Hicks PJ; Bowden DW; Chan GC; Ma L; Palmer ND; Kimberly RP; Freedman BI
Kidney Int; 2018 Sep; 94(3):599-607. PubMed ID: 29885931
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
Freedman BI; Langefeld CD; Lu L; Divers J; Comeau ME; Kopp JB; Winkler CA; Nelson GW; Johnson RC; Palmer ND; Hicks PJ; Bostrom MA; Cooke JN; McDonough CW; Bowden DW
PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
[TBL] [Abstract][Full Text] [Related]
6. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
Hicks PJ; Langefeld CD; Lu L; Bleyer AJ; Divers J; Nachman PH; Derebail VK; Bowden DW; Freedman BI
Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
[TBL] [Abstract][Full Text] [Related]
7. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
8. APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
Ma L; Langefeld CD; Comeau ME; Bonomo JA; Rocco MV; Burkart JM; Divers J; Palmer ND; Hicks PJ; Bowden DW; Lea JP; Krisher JO; Clay MJ; Freedman BI
Kidney Int; 2016 Aug; 90(2):389-395. PubMed ID: 27157696
[TBL] [Abstract][Full Text] [Related]
9. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
[TBL] [Abstract][Full Text] [Related]
10. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
[TBL] [Abstract][Full Text] [Related]
11. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
Freedman BI; Kopp JB; Langefeld CD; Genovese G; Friedman DJ; Nelson GW; Winkler CA; Bowden DW; Pollak MR
J Am Soc Nephrol; 2010 Sep; 21(9):1422-6. PubMed ID: 20688934
[TBL] [Abstract][Full Text] [Related]
12. Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
Bostrom MA; Kao WH; Li M; Abboud HE; Adler SG; Iyengar SK; Kimmel PL; Hanson RL; Nicholas SB; Rasooly RS; Sedor JR; Coresh J; Kohn OF; Leehey DJ; Thornley-Brown D; Bottinger EP; Lipkowitz MS; Meoni LA; Klag MJ; Lu L; Hicks PJ; Langefeld CD; Parekh RS; Bowden DW; Freedman BI;
Am J Kidney Dis; 2012 Feb; 59(2):210-21. PubMed ID: 22119407
[TBL] [Abstract][Full Text] [Related]
13. Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations.
Ko WY; Rajan P; Gomez F; Scheinfeldt L; An P; Winkler CA; Froment A; Nyambo TB; Omar SA; Wambebe C; Ranciaro A; Hirbo JB; Tishkoff SA
Am J Hum Genet; 2013 Jul; 93(1):54-66. PubMed ID: 23768513
[TBL] [Abstract][Full Text] [Related]
14. Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
Bailey JNC; Palmer ND; Ng MCY; Bonomo JA; Hicks PJ; Hester JM; Langefeld CD; Freedman BI; Bowden DW
Hum Genet; 2014 Jun; 133(6):769-779. PubMed ID: 24385048
[TBL] [Abstract][Full Text] [Related]
15. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
Bonomo JA; Ng MC; Palmer ND; Keaton JM; Larsen CP; Hicks PJ; ; Langefeld CD; Freedman BI; Bowden DW
Clin J Am Soc Nephrol; 2014 Aug; 9(8):1434-40. PubMed ID: 24948143
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH
Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069
[TBL] [Abstract][Full Text] [Related]
17. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
Kasembeli AN; Duarte R; Ramsay M; Mosiane P; Dickens C; Dix-Peek T; Limou S; Sezgin E; Nelson GW; Fogo AB; Goetsch S; Kopp JB; Winkler CA; Naicker S
J Am Soc Nephrol; 2015 Nov; 26(11):2882-90. PubMed ID: 25788523
[TBL] [Abstract][Full Text] [Related]
18. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
[TBL] [Abstract][Full Text] [Related]
19. APOL1 variants associate with increased risk of CKD among African Americans.
Foster MC; Coresh J; Fornage M; Astor BC; Grams M; Franceschini N; Boerwinkle E; Parekh RS; Kao WH
J Am Soc Nephrol; 2013 Sep; 24(9):1484-91. PubMed ID: 23766536
[TBL] [Abstract][Full Text] [Related]
20. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
Tzur S; Rosset S; Skorecki K; Wasser WG
Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
